These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17547889)

  • 1. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
    Denschlag D; Tan L; Patel S; Kerim-Dikeni A; Souhami L; Gilbert L
    Am J Obstet Gynecol; 2007 Jun; 196(6):546.e1-7. PubMed ID: 17547889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
    Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
    Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer.
    Patel S; Portelance L; Gilbert L; Tan L; Stanimir G; Duclos M; Souhami L
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1438-45. PubMed ID: 17418961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
    Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
    Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
    Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators of survival in advanced endometrial cancer.
    Behbakht K; Yordan EL; Casey C; DeGeest K; Massad LS; Kirschner CV; Wilbanks GD
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):363-7. PubMed ID: 7835775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.
    Paramasivam S; Tripcony L; Crandon A; Quinn M; Hammond I; Marsden D; Proietto A; Davy M; Carter J; Nicklin J; Perrin L; Obermair A
    J Clin Oncol; 2005 Sep; 23(25):5938-42. PubMed ID: 16087942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.